Fibrogen INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
FGEN
Fibrogen INCFibroGen, Inc. is holding its 2025 Annual Meeting on June 4, 2025, and stockholders are encouraged to vote on key proposals.
FGEN
Fibrogen INCFibroGen is asking stockholders to approve a reverse stock split to meet Nasdaq's minimum bid price requirement and maintain its listing.
FGEN
Fibrogen INCDEFA14A: FibroGen, Inc. to Hold Annual Meeting on June 5, 2024; Stockholders to Vote on Key Proposals
FibroGen, Inc. is holding its annual meeting on June 5, 2024, where stockholders will vote on the election of directors, approval of the 2024 Equity Incentive Plan, executive compensation, ratification of the auditor, and the frequency of executive compensation votes.
FGEN
Fibrogen INCFibroGen, Inc. announces its 2024 Annual Meeting of Stockholders to be held on June 5, 2024, featuring proposals ranging from director elections to equity incentive plan approval.